PCLO.V - PharmaCielo Ltd.

TSXV - TSXV Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 5341.8M
Enterprise Value 3309M
Trailing P/E N/A
Forward P/E 132.27
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)6.57
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-9.59

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 313.46%
52 Week High 311.5000
52 Week Low 32.5100
50-Day Moving Average 34.0151
200-Day Moving Average 35.7052

Share Statistics

Avg Vol (3 month) 3128.55k
Avg Vol (10 day) 3149.35k
Shares Outstanding 596.28M
Float 78.3M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Oct. 31, 2019) 43.46M
Short Ratio (Oct. 31, 2019) 422.27
Short % of Float (Oct. 31, 2019) 4N/A
Short % of Shares Outstanding (Oct. 31, 2019) 43.55%
Shares Short (prior month Sep. 30, 2019) 43.55M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 211/1
Last Split Date 3Jan. 18, 2019

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec. 31, 2018
Most Recent Quarter (mrq)Jun. 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-36.64k
EBITDA -32.24M
Net Income Avi to Common (ttm)-36.51M
Diluted EPS (ttm)-0.4210
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)33.46M
Total Cash Per Share (mrq)0.34
Total Debt (mrq)1.42M
Total Debt/Equity (mrq)2.73
Current Ratio (mrq)7.36
Book Value Per Share (mrq)0.54

Cash Flow Statement

Operating Cash Flow (ttm)-17.53M
Levered Free Cash Flow (ttm)N/A